
Journal of Medicinal Chemistry p. 7396 - 7415 (2013)
Update date:2022-08-15
Topics:
Surivet, Jean-Philippe
Zumbrunn, Cornelia
Rueedi, Georg
Hubschwerlen, Christian
Bur, Daniel
Bruyère, Thierry
Locher, Hans
Ritz, Daniel
Keck, Wolfgang
Seiler, Peter
Kohl, Christopher
Gauvin, Jean-Christophe
Mirre, Azely
Kaegi, Verena
Dos Santos, Marina
Gaertner, Mika
Delers, Jonathan
Enderlin-Paput, Michel
Boehme, Maria
There is an urgent need for new antibacterial drugs that are effective against infections caused by multidrug-resistant pathogens. Novel nonfluoroquinolone inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) have the potential
View MoreHangZhou HuaYe Chemical Technology Co.,Ltd
Contact:+86-13505815007
Address:hangzhou
Chengdu Gelipu Biotechnology Co., Ltd.
website:http://www.glp-china.com
Contact:86-28-82610909
Address:chegndu
suzhou chukai pharmateach co,.ltd
Contact:86-512-88812511
Address:Building 3, Wujiang Scientific Innovation Park, 2358 Changan Rd, Wujiang 215200, Jiangsu Province, P. R. China
Shanghai Yudiao Chemistry Technology Co.,Ltd
Contact:0086-18964703211
Address:Building NO.5, NO.218,Rongtian Road,ganxiang town,Jinshan District,shanghai,201518,china
WuHan rongfashun BioChemical co., LTD
Contact:02788866139
Address:No.95 LuoYu Road,Wuhan
Doi:10.1016/j.tetlet.2006.02.043
(2006)Doi:10.1002/ejoc.201301657
(2014)Doi:10.3762/bjoc.12.86
(2016)Doi:10.1039/b515616e
(2006)Doi:10.1021/jo00178a036
(1984)Doi:10.1007/s11176-005-0266-2
(2005)